PATENT CLAIM ANALYSIS

Application Number: 16084927
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-03
Patent Classification: ["514", "019300"]

Abstract:
The peptides of the invention are of formula (I) or (IV). The peptides of the invention are useful in the treatment of cancer.

Claim (Index 34):
The peptide according to  claim 33 , wherein X 3  represents a non-polar amino acid and X 4  represents a non-polar amino acid selected from Ala, Ile, Leu, Val, and Gly.

Metadata:
- Claim Count in Document: 69.0
- Percentile: 97.0
- Lexical Diversity: 1.70588
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['13984762', '14776668', '13397195', '11290735', '15581749']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7548824580344259
- 35 USC 102 Novelty (BERT): 0.5210508285352261
- Combined Prediction Score: 0.7314992950845058
- Mean Citation Score: 260.430318
- Max Citation Score: 267.25793
- Similarity Product: 168.65817990955114

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test